| Literature DB >> 33258388 |
Hyungjun Yang1, Hengameh Chloé Mirsepasi-Lauridsen2,3, Carsten Struve2, Joannie M Allaire1, Adeline Sivignon4,5, Wayne Vogl6, Else S Bosman1, Caixia Ma1, Abbas Fotovati1, Gregor S Reid1, Xiaoxia Li7, Andreas Munk Petersen8,9, Sébastien G Gouin10, Nicolas Barnich4,5, Kevan Jacobson1, Hong Bing Yu1, Karen Angeliki Krogfelt2, Bruce A Vallance1,11.
Abstract
Ulcerative colitis (UC) is a chronic inflammatory condition linked to intestinal microbial dysbiosis, including the expansion of E. coli strains related to extra-intestinal pathogenic E. coli. These "pathobionts" exhibit pathogenic properties, but their potential to promote UC is unclear due to the lack of relevant animal models. Here, we established a mouse model using a representative UC pathobiont strain (p19A), and mice lacking single immunoglobulin and toll-interleukin 1 receptor domain (SIGIRR), a deficiency increasing susceptibility to gut infections. Strain p19A was found to adhere to the cecal mucosa of Sigirr -/- mice, causing modest inflammation. Moreover, it dramatically worsened dextran sodium sulfate-induced colitis. This potentiation was attenuated using a p19A strain lacking α-hemolysin genes, or when we targeted pathobiont adherence using a p19A strain lacking the adhesin FimH, or following treatment with FimH antagonists. Thus, UC pathobionts adhere to the intestinal mucosa, and worsen the course of colitis in susceptible hosts.Entities:
Keywords: Crohn’s disease; Inflammatory bowel disease; Ulcerative Colitis; in vivo mouse model; intestinal microbiota
Year: 2020 PMID: 33258388 PMCID: PMC7781664 DOI: 10.1080/19490976.2020.1847976
Source DB: PubMed Journal: Gut Microbes ISSN: 1949-0976